960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)

M. Abdelrahim; A. Esmail; A.R. He; J. Franses; I. Bhan; David W. Victor, III; S. Kodali; A.A. Connor; A. Saharia; C. Brdiges; T. Tin; C. Brewer; A. Jurdi; M.C. Liu; R.M. Ghobrial

doi:10.1016/j.annonc.2023.09.2106

960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)

M. Abdelrahim, A. Esmail, A.R. He, J. Franses, I. Bhan, David W. Victor, III, S. Kodali, A.A. Connor, A. Saharia, C. Brdiges, T. Tin, C. Brewer, A. Jurdi, M.C. Liu, R.M. Ghobrial

Research output: Contribution to journal › Conference article

Original language	English (US)
Pages (from-to)	S600
Journal	Annals of Oncology
Volume	34
DOIs	https://doi.org/10.1016/j.annonc.2023.09.2106
State	Unpublished - Oct 20 2023
Event	European Society for Medical Oncology (ESMO) Congress - Duration: Jan 1 2000 → …

Access to Document

10.1016/j.annonc.2023.09.2106

https://www.sciencedirect.com/science/article/pii/S0923753423029435

Cite this

Abdelrahim, M., Esmail, A., He, A. R., Franses, J., Bhan, I., Victor, III, D. W., Kodali, S., Connor, A. A., Saharia, A., Brdiges, C., Tin, T., Brewer, C., Jurdi, A., Liu, M. C., & Ghobrial, R. M. (2023). 960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC). Unpublished. https://doi.org/10.1016/j.annonc.2023.09.2106

Abdelrahim, M , Esmail, A, He, AR, Franses, J, Bhan, I, Victor, III, DW , Kodali, S , Connor, AA , Saharia, A, Brdiges, C, Tin, T, Brewer, C, Jurdi, A, Liu, MC & Ghobrial, RM 2023, '960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)', Annals of Oncology, vol. 34, pp. S600. https://doi.org/10.1016/j.annonc.2023.09.2106

@article{c68bee961c2a4021abaed82642a3736a,

title = "960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)",

author = "M. Abdelrahim and A. Esmail and A.R. He and J. Franses and I. Bhan and {Victor, III}, {David W.} and S. Kodali and A.A. Connor and A. Saharia and C. Brdiges and T. Tin and C. Brewer and A. Jurdi and M.C. Liu and R.M. Ghobrial",

note = "Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.; European Society for Medical Oncology (ESMO) Congress ; Conference date: 01-01-2000",

year = "2023",

month = oct,

day = "20",

doi = "10.1016/j.annonc.2023.09.2106",

language = "English (US)",

volume = "34",

pages = "S600",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - 960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)

AU - Abdelrahim, M.

AU - Esmail, A.

AU - He, A.R.

AU - Franses, J.

AU - Bhan, I.

AU - Victor, III, David W.

AU - Kodali, S.

AU - Connor, A.A.

AU - Saharia, A.

AU - Brdiges, C.

AU - Tin, T.

AU - Brewer, C.

AU - Jurdi, A.

AU - Liu, M.C.

AU - Ghobrial, R.M.

N1 - Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.

PY - 2023/10/20

Y1 - 2023/10/20

U2 - 10.1016/j.annonc.2023.09.2106

DO - 10.1016/j.annonc.2023.09.2106

M3 - Conference article

SN - 0923-7534

VL - 34

SP - S600

JO - Annals of Oncology

JF - Annals of Oncology

T2 - European Society for Medical Oncology (ESMO) Congress

Y2 - 1 January 2000

ER -